Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / ALDX - Why Aldeyra Therapeutics (ALDX) Stock Is Getting Obliterated | Benzinga

ALDX - Why Aldeyra Therapeutics (ALDX) Stock Is Getting Obliterated | Benzinga

Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc (NASDAQ: ALDX) shares are trading lower by 62% to $2.07 during Monday's pre-market session. The company on Monday morning received feedback from the U.S. Food and Drug Administration (FDA) regarding their new drug application (NDA) for reproxalap, intended for treating dry eye disease.

The FDA says it identified significant issues with the clinical data supporting the drug's effectiveness for this indication.

See Also: Drug Retailer Rite Aid Grappling With ...

ALDX) Stock Is Getting Obliterated>Full story available on Benzinga.com
Stock Information
Company Name: Aldeyra Therapeutics Inc.
Stock Symbol: ALDX
Market: NASDAQ
Website: aldeyra.com
Menu
ALDX ALDX Quote ALDX Short ALDX News ALDX Articles ALDX Message Board
Get ALDX Alerts

News, Short Squeeze, Breakout and More Instantly...